As the Vice President and Head of Medical Affairs for US Oncology Business Unit, Carlos Doti, MD, leads the teams responsible for the development and delivery of the medical strategy across AstraZeneca’s US oncology portfolio. Since joining AstraZeneca in 2016, he has held various Medical Affairs leadership roles within the Oncology Business Unit within the International markets and on a Global level. Most recently, he served as the Global Medical Franchise Head of Hematology where he led the delivery of integrated confidence and evidence generation plans, while implementing new development initiatives.
Prior to joining AstraZeneca, he was with Pfizer and Novo Nordisk where he served in various leadership roles in Latin America Medical Affairs. He received his MD from the University of Buenos Aires, where he specialized in hematology. As a practicing physician, he specialized in hematology and bone marrow transplant.
Underrepresentation of racial and ethnic groups and other historically disenfranchised populations in clinical trials continues to be a major challenge. Medical Affairs can help identify solutions.